MYC and neoplasm: Zhu et al. reported that SRGN promotes tumour invasion and metastasis in oesophageal squamous cell carcinoma via the SRGN/MDK/CD44 complex to activate the ERK pathway, stabilise c-Myc, and upregulate the secretion of matrix metalloproteinases [36].